
Liquidity, historical trends, and peer comparisons.
According to InflaRx N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 8.22. This represents a change of 65.67% compared to the average of 4.96 of the last 4 quarters.
The mean historical Current Ratio of InflaRx N.V. over the last ten years is 10.85. The current 8.22 Current Ratio has changed -24.26% with respect to the historical average. Over the past ten years (40 quarters), IFRX's Current Ratio was at its highest in in the June 2018 quarter at 43.98. The Current Ratio was at its lowest in in the September 2016 quarter at 0.
Average
10.85
Median
7.97
Minimum
4.13
Maximum
26.01
Discovering the peaks and valleys of InflaRx N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 111.50%
Maximum Annual Current Ratio = 26.01
Minimum Annual Increase = -58.50%
Minimum Annual Current Ratio = 4.13
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 4.13 | -18.32% |
| 2024 | 5.06 | -22.17% |
| 2023 | 6.50 | -13.10% |
| 2022 | 7.48 | 46.60% |
| 2021 | 5.10 | -40.30% |
| 2020 | 8.54 | 0.97% |
| 2019 | 8.46 | -58.50% |
| 2018 | 20.39 | -21.59% |
| 2017 | 26.01 | 54.55% |
| 2016 | 16.83 | 111.50% |
The current Current Ratio of InflaRx N.V. (IFRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
5.23
5-year avg
5.65
10-year avg
10.85
InflaRx N.V.’s Current Ratio is less than Shattuck Labs, Inc. (27.59), greater than Connect Biopharma Holdings Limited (2.37), less than ImageneBio Inc (21.47), less than Kalaris Therapeutics Inc (10.98), less than Artiva Biotherapeutics, Inc. (24.16), greater than Sutro Biopharma, Inc. (3.32), less than Quince Therapeutics, Inc. (14.52), greater than Metagenomi, Inc. Common Stock (4.50), greater than Context Therapeutics Inc. (5.81), greater than aTyr Pharma, Inc. (5.12),
| Company | Current Ratio | Market cap |
|---|---|---|
| 27.59 | $525.90M | |
| 2.37 | $50.44M | |
| 21.47 | $45.97M | |
| 10.98 | $43.03M | |
| 24.16 | $203.17M | |
| 3.32 | $150.14M | |
| 14.52 | $8.83M | |
| 4.50 | $30.13M | |
| 5.81 | $18.10M | |
| 5.12 | $14.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InflaRx N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InflaRx N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is InflaRx N.V.'s Current Ratio?
How is the Current Ratio calculated for InflaRx N.V. (IFRX)?
What is the highest Current Ratio for InflaRx N.V. (IFRX)?
What is the 3-year average Current Ratio for InflaRx N.V. (IFRX)?
What is the 5-year average Current Ratio for InflaRx N.V. (IFRX)?
How does the current Current Ratio for InflaRx N.V. (IFRX) compare to its historical average?